Examkin

Soru

Zorluk: OrtaNeonatal Disorders

A 24-hour-old term male neonate is evaluated in the nursery for rapidly progressing jaundice. He was born via uncomplicated vaginal delivery at 39 weeks gestation to a mother with blood type O, Rh-positive. His birth weight was 3400 g3400\text{ g}. APGAR scores were 8 and 9 at 1 and 5 minutes, respectively. The infant's blood type is A, Rh-positive, and his direct antiglobulin test (DAT) is strongly positive. He is currently vigorous and feeding well with breast milk. His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), heart rate is 145/min145\text{/min}, and respiratory rate is 42/min42\text{/min}. Arrange the following interventions in the most appropriate escalating sequence for the management of this patient's condition, assuming continued clinical deterioration and refractoriness to each preceding therapy.

  1. 1Measure total and conjugated serum bilirubin levels
  2. 2Initiate intensive phototherapy
  3. 3Administer intravenous immunoglobulin (IVIG)
  4. 4Perform a double-volume exchange transfusion

Cevap

The correct escalating sequence is: Measure total and conjugated serum bilirubin levels → Initiate intensive phototherapy → Administer intravenous immunoglobulin (IVIG) → Perform a double-volume exchange transfusion.
The management of pathologic neonatal hyperbilirubinemia follows a stepwise, escalating protocol. The first mandatory step is obtaining a total and conjugated serum bilirubin level to risk-stratify the infant using an hour-specific nomogram. Once identified as high-risk, intensive phototherapy is the first-line treatment to increase bilirubin excretion. In cases of isoimmune hemolytic disease (such as the ABO incompatibility seen in this patient with a positive DAT), intravenous immunoglobulin (IVIG) is indicated if the bilirubin level continues to rise despite intensive phototherapy. Finally, a double-volume exchange transfusion is reserved as the ultimate rescue therapy if the bilirubin level nears critical neurotoxic thresholds or if the infant develops signs of acute bilirubin encephalopathy.

Adım Adım Çözüm

1
Evaluate the clinical presentation and risk factors.
The infant has jaundice in the first 24 hours of life with ABO incompatibility (Mother O, Infant A) and a positive DAT.
This indicates pathologic isoimmune hemolytic disease requiring immediate evaluation.
2
Determine the initial diagnostic step.
Measure total and conjugated serum bilirubin levels.
A baseline bilirubin level must be plotted on an hour-specific nomogram to guide treatment thresholds before any therapy is initiated.
3
Identify the first-line therapeutic intervention.
Initiate intensive phototherapy.
Phototherapy structurally converts bilirubin into excretable isomers and is the standard initial therapy for hyperbilirubinemia.
4
Identify the adjunctive therapy for refractory isoimmune hemolysis.
Administer intravenous immunoglobulin (IVIG).
If bilirubin rises despite phototherapy in isoimmune hemolysis, IVIG blocks Fc receptors on macrophages, reducing red blood cell destruction.
5
Determine the ultimate rescue therapy.
Perform a double-volume exchange transfusion.
If bilirubin levels reach critically high thresholds despite phototherapy and IVIG, or if neurologic signs develop, exchange transfusion rapidly removes bilirubin and maternal antibodies.

Anahtar Kavram

The escalating management of neonatal isoimmune hemolytic hyperbilirubinemia involves baseline bilirubin measurement, followed by intensive phototherapy, adjunctive IVIG for refractory cases, and ultimately exchange transfusion for critically high levels.
Bu soruyu puanla

Konular

Neonatal Disorders

Bu konudan daha fazla soru